Literature DB >> 28667669

Optogenetic stimulation of dentate gyrus engrams restores memory in Alzheimer's disease mice.

Jennifer N Perusini1,2, Stephanie A Cajigas1, Omid Cohensedgh1, Sean C Lim2,3, Ina P Pavlova2, Zoe R Donaldson1,2,4, Christine A Denny1,2.   

Abstract

Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by amyloid-beta (Aβ) plaques and tau neurofibrillary tangles. APPswe/PS1dE9 (APP/PS1) mice have been developed as an AD model and are characterized by plaque formation at 4-6 months of age. Here, we sought to better understand AD-related cognitive decline by characterizing various types of memory. In order to better understand how memory declines with AD, APP/PS1 mice were bred with ArcCreERT2 mice. In this line, neural ensembles activated during memory encoding can be indelibly tagged and directly compared with neural ensembles activated during memory retrieval (i.e., memory traces/engrams). We first administered a battery of tests examining depressive- and anxiety-like behaviors, as well as spatial, social, and cognitive memory to APP/PS1 × ArcCreERT2 × channelrhodopsin (ChR2)-enhanced yellow fluorescent protein (EYFP) mice. Dentate gyrus (DG) neural ensembles were then optogenetically stimulated in these mice to improve memory impairment. AD mice had the most extensive differences in fear memory, as assessed by contextual fear conditioning (CFC), which was accompanied by impaired DG memory traces. Optogenetic stimulation of DG neural ensembles representing a CFC memory increased memory retrieval in the appropriate context in AD mice when compared with control (Ctrl) mice. Moreover, optogenetic stimulation facilitated reactivation of the neural ensembles that were previously activated during memory encoding. These data suggest that activating previously learned DG memory traces can rescue cognitive impairments and point to DG manipulation as a potential target to treat memory loss commonly seen in AD.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's; Arc; engram; hippocampus; optogenetics

Mesh:

Substances:

Year:  2017        PMID: 28667669      PMCID: PMC5610644          DOI: 10.1002/hipo.22756

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  36 in total

1.  Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

Authors:  J L Jankowsky; H H Slunt; T Ratovitski; N A Jenkins; N G Copeland; D R Borchelt
Journal:  Biomol Eng       Date:  2001-06

2.  A novel ARC gene polymorphism is associated with reduced risk of Alzheimer's disease.

Authors:  Sara Landgren; Malin von Otter; Mona Seibt Palmér; Caroline Zetterström; Staffan Nilsson; Ingmar Skoog; Deborah R Gustafson; Lennart Minthon; Anders Wallin; Niels Andreasen; Nenad Bogdanovic; Jan Marcusson; Kaj Blennow; Henrik Zetterberg; Petronella Kettunen
Journal:  J Neural Transm (Vienna)       Date:  2012-05-25       Impact factor: 3.575

3.  False recollection of emotional pictures in Alzheimer's disease.

Authors:  David A Gallo; Katherine T Foster; Jessica T Wong; David A Bennett
Journal:  Neuropsychologia       Date:  2010-08-19       Impact factor: 3.139

4.  Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites.

Authors:  G L Lyford; K Yamagata; W E Kaufmann; C A Barnes; L K Sanders; N G Copeland; D J Gilbert; N A Jenkins; A A Lanahan; P F Worley
Journal:  Neuron       Date:  1995-02       Impact factor: 17.173

5.  Arrest of adult hippocampal neurogenesis in mice impairs single- but not multiple-trial contextual fear conditioning.

Authors:  Michael R Drew; Christine A Denny; Rene Hen
Journal:  Behav Neurosci       Date:  2010-08       Impact factor: 1.912

6.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

7.  The Global Deterioration Scale for assessment of primary degenerative dementia.

Authors:  B Reisberg; S H Ferris; M J de Leon; T Crook
Journal:  Am J Psychiatry       Date:  1982-09       Impact factor: 18.112

8.  Early-versus late-onset Alzheimer's disease: more than age alone.

Authors:  Esther L G E Koedam; Vivian Lauffer; Annelies E van der Vlies; Wiesje M van der Flier; Philip Scheltens; Yolande A L Pijnenburg
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

9.  Improved specificity of hippocampal memory trace labeling.

Authors:  Alejandro S Cazzulino; Randy Martinez; Nicole K Tomm; Christine A Denny
Journal:  Hippocampus       Date:  2016-01-20       Impact factor: 3.899

10.  Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease.

Authors:  Dheeraj S Roy; Autumn Arons; Teryn I Mitchell; Michele Pignatelli; Tomás J Ryan; Susumu Tonegawa
Journal:  Nature       Date:  2016-03-16       Impact factor: 49.962

View more
  20 in total

1.  Persistent increases of PKMζ in memory-activated neurons trace LTP maintenance during spatial long-term memory storage.

Authors:  Changchi Hsieh; Panayiotis Tsokas; Alejandro Grau-Perales; Edith Lesburguères; Joseph Bukai; Kunal Khanna; Joelle Chorny; Ain Chung; Claudia Jou; Nesha S Burghardt; Christine A Denny; Rafael E Flores-Obando; Benjamin Rush Hartley; Laura Melissa Rodríguez Valencia; A Iván Hernández; Peter J Bergold; James E Cottrell; Juan Marcos Alarcon; André Antonio Fenton; Todd Charlton Sacktor
Journal:  Eur J Neurosci       Date:  2021-02-04       Impact factor: 3.386

Review 2.  Regulation of intrinsic excitability: Roles for learning and memory, aging and Alzheimer's disease, and genetic diversity.

Authors:  Amy R Dunn; Catherine C Kaczorowski
Journal:  Neurobiol Learn Mem       Date:  2019-08-20       Impact factor: 2.877

3.  Neuronal network dysfunction precedes storage and neurodegeneration in a lysosomal storage disorder.

Authors:  Rebecca C Ahrens-Nicklas; Luis Tecedor; Arron F Hall; Elena Lysenko; Akiva S Cohen; Beverly L Davidson; Eric D Marsh
Journal:  JCI Insight       Date:  2019-11-01

Review 4.  New era of optogenetics: from the central to peripheral nervous system.

Authors:  Xiang Xu; Thomas Mee; Xiaofeng Jia
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-02-18       Impact factor: 8.250

5.  Optogenetic reactivation of prefrontal social neural ensembles mimics social buffering of fear.

Authors:  Vanessa A Gutzeit; Kylia Ahuna; Tabia L Santos; Ashley M Cunningham; Meghin Sadsad Rooney; Andrea Muñoz Zamora; Christine A Denny; Zoe R Donaldson
Journal:  Neuropsychopharmacology       Date:  2020-02-08       Impact factor: 7.853

Review 6.  Memory engrams: Recalling the past and imagining the future.

Authors:  Sheena A Josselyn; Susumu Tonegawa
Journal:  Science       Date:  2020-01-03       Impact factor: 47.728

Review 7.  The neurobiological foundation of memory retrieval.

Authors:  Paul W Frankland; Sheena A Josselyn; Stefan Köhler
Journal:  Nat Neurosci       Date:  2019-09-24       Impact factor: 24.884

8.  Loss of CELF6 RNA binding protein impairs cocaine conditioned place preference and contextual fear conditioning.

Authors:  Susan E Maloney; Michael A Rieger; Ream Al-Hasani; Michael R Bruchas; David F Wozniak; Joseph D Dougherty
Journal:  Genes Brain Behav       Date:  2019-06-19       Impact factor: 3.708

9.  Propranolol Decreases Fear Expression by Modulating Fear Memory Traces.

Authors:  Sofia Leal Santos; Michelle Stackmann; Andrea Muñoz Zamora; Alessia Mastrodonato; Allegra V De Landri; Nick Vaughan; Briana K Chen; Marcos Lanio; Christine A Denny
Journal:  Biol Psychiatry       Date:  2021-01-20       Impact factor: 12.810

10.  Acute gene expression changes in the mouse hippocampus following a combined Gulf War toxicant exposure.

Authors:  Kathleen E Murray; Vedad Delic; Whitney A Ratliff; Kevin D Beck; Bruce A Citron
Journal:  Life Sci       Date:  2021-07-20       Impact factor: 5.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.